BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24495796)

  • 1. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
    Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
    Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of irradiation-induced mammary cancer metastasis: A role for SAP-dependent Mkl1 signaling.
    Asparuhova MB; Secondini C; Rüegg C; Chiquet-Ehrismann R
    Mol Oncol; 2015 Oct; 9(8):1510-27. PubMed ID: 25999144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress.
    Asparuhova MB; Ferralli J; Chiquet M; Chiquet-Ehrismann R
    FASEB J; 2011 Oct; 25(10):3477-88. PubMed ID: 21705668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
    Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
    Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.
    Muehlich S; Hampl V; Khalid S; Singer S; Frank N; Breuhahn K; Gudermann T; Prywes R
    Oncogene; 2012 Aug; 31(35):3913-23. PubMed ID: 22139079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
    Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
    Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells.
    Du KL; Chen M; Li J; Lepore JJ; Mericko P; Parmacek MS
    J Biol Chem; 2004 Apr; 279(17):17578-86. PubMed ID: 14970199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines.
    Kerdivel G; Boudot A; Habauzit D; Percevault F; Demay F; Pakdel F; Flouriot G
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):34-44. PubMed ID: 24721635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.
    Littlepage LE; Adler AS; Kouros-Mehr H; Huang G; Chou J; Krig SR; Griffith OL; Korkola JE; Qu K; Lawson DA; Xue Q; Sternlicht MD; Dijkgraaf GJ; Yaswen P; Rugo HS; Sweeney CA; Collins CC; Gray JW; Chang HY; Werb Z
    Cancer Discov; 2012 Jul; 2(7):638-51. PubMed ID: 22728437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryoblastic leukemia protein-1 (MKL1): Increasing evidence for an involvement in cancer progression and metastasis.
    Scharenberg MA; Chiquet-Ehrismann R; Asparuhova MB
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1911-4. PubMed ID: 20816842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.
    Samaeekia R; Adorno-Cruz V; Bockhorn J; Chang YF; Huang S; Prat A; Ha N; Kibria G; Huo D; Zheng H; Dalton R; Wang Y; Moskalenko GY; Liu H
    Clin Cancer Res; 2017 Feb; 23(4):1091-1103. PubMed ID: 27435395
    [No Abstract]   [Full Text] [Related]  

  • 12. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via a SPOC domain that is required for cytokine-independent proliferation.
    Lee JH; Skalnik DG
    PLoS One; 2012; 7(8):e42965. PubMed ID: 22927943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
    Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
    J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
    Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for MKL1 in megakaryocytic maturation.
    Cheng EC; Luo Q; Bruscia EM; Renda MJ; Troy JA; Massaro SA; Tuck D; Schulz V; Mane SM; Berliner N; Sun Y; Morris SW; Qiu C; Krause DS
    Blood; 2009 Mar; 113(12):2826-34. PubMed ID: 19136660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of the estrogen receptor-alpha transcriptional activity by the Rho/megakaryoblastic leukemia 1 signaling pathway.
    Huet G; Mérot Y; Percevault F; Tiffoche C; Arnal JF; Boujrad N; Pakdel F; Métivier R; Flouriot G
    J Biol Chem; 2009 Dec; 284(49):33729-39. PubMed ID: 19826002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis.
    Yang X; Vasudevan P; Parekh V; Penev A; Cunningham JM
    PLoS One; 2013; 8(2):e56195. PubMed ID: 23441166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
    Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
    Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.
    Sun M; Song CX; Huang H; Frankenberger CA; Sankarasharma D; Gomes S; Chen P; Chen J; Chada KK; He C; Rosner MR
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9920-5. PubMed ID: 23716660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.